OX40 ligand stim 
Welcome,         Profile    Billing    Logout  
  Companies   Products    Products    Diseases    Trials    News 
3 Trials

   

Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
DNX-2440 / DNAtrix
NCT04714983: DNX-2440 for Resectable Colorectal Liver Metastasis

Suspended
1
30
US
DNX-2440
DNAtrix, Inc., H. Lee Moffitt Cancer Center and Research Institute
Liver Metastases, Liver Metastasis Colon Cancer, Colorectal Cancer, Breast Cancer, Gastric Cancer, Periampullary Cancer, Melanoma, Renal Cell Cancer, Sarcoma, Squamous Cell Carcinoma, Gastrointestinal Stromal Tumors
07/26
12/26
NCT03714334: DNX-2440 Oncolytic Adenovirus for Recurrent Glioblastoma

Terminated
1
16
Europe
DNX-2440 injection
Clinica Universidad de Navarra, Universidad de Navarra, DNAtrix, Inc.
Glioblastoma, Glioblastoma, Adult
04/23
04/23
PeptiCRAd-1 / Valo Tx
NCT05492682: START: Safety and Anti-Tumor Activity of PeptiCRAd-1 in Treatment of Cancer

Recruiting
1
15
Europe
PeptiCRAd-1, Cyclophosphamide, Pembrolizumab
Valo Therapeutics Oy
Melanoma (Skin), Triple-Negative Breast Cancer, Non-Small Cell Lung Cancer, Synovial Sarcoma, Myxoid Liposarcoma, Colorectal Cancer, Osteosarcoma, Sarcoma
06/25
09/25
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
DNX-2440 / DNAtrix
NCT04714983: DNX-2440 for Resectable Colorectal Liver Metastasis

Suspended
1
30
US
DNX-2440
DNAtrix, Inc., H. Lee Moffitt Cancer Center and Research Institute
Liver Metastases, Liver Metastasis Colon Cancer, Colorectal Cancer, Breast Cancer, Gastric Cancer, Periampullary Cancer, Melanoma, Renal Cell Cancer, Sarcoma, Squamous Cell Carcinoma, Gastrointestinal Stromal Tumors
07/26
12/26
NCT03714334: DNX-2440 Oncolytic Adenovirus for Recurrent Glioblastoma

Terminated
1
16
Europe
DNX-2440 injection
Clinica Universidad de Navarra, Universidad de Navarra, DNAtrix, Inc.
Glioblastoma, Glioblastoma, Adult
04/23
04/23
PeptiCRAd-1 / Valo Tx
NCT05492682: START: Safety and Anti-Tumor Activity of PeptiCRAd-1 in Treatment of Cancer

Recruiting
1
15
Europe
PeptiCRAd-1, Cyclophosphamide, Pembrolizumab
Valo Therapeutics Oy
Melanoma (Skin), Triple-Negative Breast Cancer, Non-Small Cell Lung Cancer, Synovial Sarcoma, Myxoid Liposarcoma, Colorectal Cancer, Osteosarcoma, Sarcoma
06/25
09/25

Download Options